Firefly Neuroscience, Inc. (AIFF) stock price

Firefly Neuroscience, Inc. (AIFF) is a Technology · Software - Application company listed on NASDAQ. Price $1.31 (+2.34%), Market cap $0.03B, 52-week low–high $0.64 ~ $3.46.

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Firefly Neuroscience, Inc. are updated in real time on BlackAll Trade.

Firefly Neuroscience, Inc. financial summary

Key ratios · profitability · growth

Frequently asked questions

What is the current Firefly Neuroscience, Inc. (AIFF) stock price?

Firefly Neuroscience, Inc. trades at $1.31 (+2.34%). Real-time quotes and charts are available on BlackAll Trade.

What is the Firefly Neuroscience, Inc. (AIFF) market cap?

Firefly Neuroscience, Inc. has a market cap of about $0.03B.

What does Firefly Neuroscience, Inc. (AIFF) do?

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the compl